Related references
Note: Only part of the references are listed.Association of SELP Polymorphisms with Soluble P-Selectin Levels and Vascular Risk in Patients with Type 2 Diabetes Mellitus: A Case-Control Study
Raminderjit Kaur et al.
BIOCHEMICAL GENETICS (2019)
Acenocoumarol as an alternative anticoagulant in a patient with warfarin-related nephropathy
Sapan Kumar Behera et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
miR-29 contributes to normal endothelial function and can restore it in cardiometabolic disorders
Michael E. Widlansky et al.
EMBO MOLECULAR MEDICINE (2018)
Comparison of the effects of linagliptin and voglibose on endothelial function in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, pilot study (EFFORT)
Taku Koyama et al.
HEART AND VESSELS (2018)
Insulin resistance adipocyte-derived exosomes aggravate atherosclerosis by increasing vasa vasorum angiogenesis in diabetic ApoE-/- mice
Feng Wang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes
Bin Wang et al.
REDOX BIOLOGY (2018)
The Potential Role of Platelet-Related microRNAs in the Development of Cardiovascular Events in High-Risk Populations, Including Diabetic Patients: A Review
Justyna Pordzik et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Patients with an Inflamed Atherosclerotic Plaque have Increased Levels of Circulating Inflammatory Markers
Pavel Poredos et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2017)
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
J. I. Weitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Fiber-rich diet with brown rice improves endothelial function in type 2 diabetes mellitus: A randomized controlled trial
Keiko Kondo et al.
PLOS ONE (2017)
Interaction of IL-6 and TNF-α contributes to endothelial dysfunction in type 2 diabetic mouse hearts
Jonghae Lee et al.
PLOS ONE (2017)
Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report
Kyoung Min Kim et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study
Anna Solini et al.
CARDIOVASCULAR DIABETOLOGY (2017)
High-density lipoproteins attenuate high glucose-impaired endothelial cell signaling and functions: potential implications for improved vascular repair in diabetes
Xing Chen et al.
CARDIOVASCULAR DIABETOLOGY (2017)
The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation
Sanam Ebtehaj et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Thrombotic and cardiovascular risks in type two diabetes; Role of platelet hyperactivity
Almottesembellah Gaiz et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control
F. Casanova et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Impact of Glycemic Variability on Chromatin Remodeling, Oxidative Stress, and Endothelial Dysfunction in Patients With Type 2 Diabetes and With Target HbA1c Levels
Sarah Costantino et al.
DIABETES (2017)
Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study
Fumika Shigiyama et al.
CARDIOVASCULAR DIABETOLOGY (2017)
T-cadherin deficiency increases vascular vulnerability in T2DM through impaired NO bioactivity
Han Wang et al.
CARDIOVASCULAR DIABETOLOGY (2017)
A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes
Thomas Jax et al.
CARDIOVASCULAR DIABETOLOGY (2017)
The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction
Arpeeta Sharma et al.
CARDIOVASCULAR DIABETOLOGY (2017)
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
Christian Ott et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Endothelin-1 Overexpression Exaggerates Diabetes-Induced Endothelial Dysfunction by Altering Oxidative Stress
Noureddine Idris-Khodja et al.
AMERICAN JOURNAL OF HYPERTENSION (2016)
Endothelial Dysfunction in Human Diabetes Is Mediated by Wnt5a-JNK Signaling
Rosa Breton-Romero et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling
Jessica L. Fetterman et al.
ATHEROSCLEROSIS (2016)
New antiplatelet drugs and new oral anticoagulants
V. Koenig-Oberhuber et al.
BRITISH JOURNAL OF ANAESTHESIA (2016)
Insulin resistance, endothelial function, angiogenic factors and clinical outcome in non-diabetic patients with chest pain without myocardial perfusion defects
Helena U. Westergren et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes
Andrew O. Odegaard et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Circulating cellular adhesion molecules and risk of diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA)
J. S. Pankow et al.
DIABETIC MEDICINE (2016)
Serum Markers of Endothelial Dysfunction and Inflammation Increase in Hypertension with Prediabetes Mellitus
Zhouqing Huang et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2016)
Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease
Chihiro Mitsui et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Atrial fibrillation is associated with high levels of monocyte-platelet-aggregates and increased CD11b expression in patients with aortic stenosis
Christian Pfluecke et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis
Thomas Gremmel et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Microparticles as new markers of cardiovascular risk in diabetes and beyond
Francesca Santilli et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study
Markus F. Scheerer et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2016)
Circulating Microparticles and Coronary Plaque Components Assessed by Virtual Histology Intravascular Ultrasound of the Target Lesion in Patients with Stable Angina
Pil-Ki Min et al.
PLOS ONE (2016)
Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies
Sabrina Schlesinger et al.
PLOS ONE (2016)
Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse
Hotimah Masdan Salim et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2016)
Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation
Shiro Fukuda et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
Keiichi Torimoto et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Platelet miRNAs and cardiovascular diseases
Eduardo Fuentes et al.
LIFE SCIENCES (2015)
Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing
Matthias K. Freynhofer et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Asymmetric Dimethylarginine and Cardiovascular Risk: Systematic Review and Meta-Analysis of 22 Prospective Studies
Peter Willeit et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
THERAPY OF ENDOCRINE DISEASE Effects of chronic use of phosphodiesterase inhibitors on endothelial markers in type 2 diabetes mellitus: a meta-analysis
Daniele Santi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Wnt5a: A player in the pathogenesis of atherosclerosis and other inflammatory disorders
Pooja M. Bhatt et al.
ATHEROSCLEROSIS (2014)
Do incretins improve endothelial function?
Jun-ichi Oyama et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Adiponectin/T-cadherin and apelin/APJ expression in human arteries and periadventitial fat: implication of local adipokine signaling in atherosclerosis?
Christos G. Kostopoulos et al.
CARDIOVASCULAR PATHOLOGY (2014)
Dapagliflozin treatment for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
Mei Zhang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2014)
Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status
Xuguang Zhang et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2014)
Combating oxidative stress in diabetic complications with Nrf2 activators: How much is too much?
Sih Min Tan et al.
REDOX REPORT (2014)
Overview of Platelet Physiology: Its Hemostatic and Nonhemostatic Role in Disease Pathogenesis
Kakali Ghoshal et al.
SCIENTIFIC WORLD JOURNAL (2014)
Relation of Asymmetric Dimethylarginine Levels to Macrovascular Disease and Inflammation Markers in Type 2 Diabetic Patients
Mustafa Celik et al.
JOURNAL OF DIABETES RESEARCH (2014)
Endothelial dysfunction - A major mediator of diabetic vascular disease
Cristina M. Sena et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Perioperative management of antiplatelet therapy
A. D. Oprea et al.
BRITISH JOURNAL OF ANAESTHESIA (2013)
New Oral Anticoagulants: Comparative Pharmacology with Vitamin K Antagonists
Francesco Scaglione
CLINICAL PHARMACOKINETICS (2013)
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Francesco Paneni et al.
EUROPEAN HEART JOURNAL (2013)
T-cadherin Is Essential for Adiponectin-mediated Revascularization
Jennifer L. Parker-Duffen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
WNT-3A and WNT-5A counteract lipopolysaccharide-induced pro-inflammatory changes in mouse primary microglia
Carina Halleskog et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Revisited role of microparticles in arterial and venous thrombosis
R. Lacroix et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Role of insulin resistance in endothelial dysfunction
Ranganath Muniyappa et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2013)
Role of microRNAs in diabetes and its cardiovascular complications
Saran Shantikumar et al.
CARDIOVASCULAR RESEARCH (2012)
Parenteral Anticoagulants Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
David A. Garcia et al.
CHEST (2012)
New Antithrombotic Drugs Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Jeffrey I. Weitz et al.
CHEST (2012)
MicroRNAs in Vascular and Metabolic Disease
Anna Zampetaki et al.
CIRCULATION RESEARCH (2012)
Urinary F-2-Isoprostanes as a Biomarker of Reduced Risk of Type 2 Diabetes
Dora Il'yasova et al.
DIABETES CARE (2012)
The Relationship Between Diabetes, Metabolic Syndrome, and Platelet Activity as Measured by Mean Platelet Volume The National Health and Nutrition Examination Survey, 1999-2004
Binita Shah et al.
DIABETES CARE (2012)
Protective Effects of Flavanol-Rich Dark Chocolate on Endothelial Function and Wave Reflection During Acute Hyperglycemia
Davide Grassi et al.
HYPERTENSION (2012)
MicroRNAs and Type 2 Diabetes/Obesity
Mustafa Abdo Saif Dehwah et al.
JOURNAL OF GENETICS AND GENOMICS (2012)
From excess adiposity to insulin resistance: The role of free fatty acids
Cristiano Capurso et al.
VASCULAR PHARMACOLOGY (2012)
Antiplatelet Drugs: A Review of Their Pharmacology and Management in the Perioperative Period
Richard Hall et al.
ANESTHESIA AND ANALGESIA (2011)
Deregulation of microRNA-503 Contributes to Diabetes Mellitus-Induced Impairment of Endothelial Function and Reparative Angiogenesis After Limb Ischemia
Andrea Caporali et al.
CIRCULATION (2011)
Aspirin A Historical and Contemporary Therapeutic Overview
Valentin Fuster et al.
CIRCULATION (2011)
Endothelial Dysfunction in Diabetes The role of reparatory mechanisms
Angelo Avogaro et al.
DIABETES CARE (2011)
Antiplatelet agents for the treatment and prevention of atherothrombosis
Carlo Patrono et al.
EUROPEAN HEART JOURNAL (2011)
MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes Mellitus
Dwi Setyowati Karolina et al.
PLOS ONE (2011)
Platelet Function in Patients with Diabetes Mellitus: From a Theoretical to a Practical Perspective
Nicholaos Kakouros et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2011)
Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2
Henryk Dreger et al.
CARDIOVASCULAR RESEARCH (2010)
Update on Antithrombotic Therapy New Anticoagulants
John W. Eikelboom et al.
CIRCULATION (2010)
Oxidative Stress and Diabetic Complications
Ferdinando Giacco et al.
CIRCULATION RESEARCH (2010)
Platelet abnormalities in diabetes mellitus
Jose Luis Ferreiro et al.
DIABETES & VASCULAR DISEASE RESEARCH (2010)
Point: Postprandial Glucose Levels Are a Clinically Important Treatment Target
Antonio Ceriello
DIABETES CARE (2010)
Impact of Cytochrome P450 2C19 Loss-of-Function Polymorphism and of Major Demographic Characteristics on Residual Platelet Function After Loading and Maintenance Treatment With Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
Willibald Hochholzer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Determination of the Prevalence of Aspirin and Clopidogrel Resistances in Patients with Coronary Artery Disease by using Various Platelet-function Tests
Kwang-Sook Woo et al.
KOREAN JOURNAL OF LABORATORY MEDICINE (2010)
The Nrf2 System as a Potential Target for the Development of Indirect Antioxidants
Kyeong-Ah Jung et al.
MOLECULES (2010)
Circulating Endothelial Microparticles in Diabetes Mellitus
A. F. Tramontano et al.
MEDIATORS OF INFLAMMATION (2010)
In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin
Isabella Russo et al.
OBESITY (2010)
Matrix Metalloproteinase-10 Is Upregulated by Thrombin in Endothelial Cells and Increased in Patients With Enhanced Thrombin Generation
Josune Orbe et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux
Anna C. Calkin et al.
CIRCULATION (2009)
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association
Jay S. Skyler et al.
CIRCULATION (2009)
Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets
Maria Assunta Potenza et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Insulin, Insulin Resistance, and Platelet Signaling in Diabetes
Voahanginirina Randriamboavonjy et al.
DIABETES CARE (2009)
Association Between Increased Platelet P-Selectin Expression and Obesity in Patients With Type 2 Diabetes A BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy
David J. Schneider et al.
DIABETES CARE (2009)
Oxidative Stress and Insulin Resistance The Coronary Artery Risk Development in Young Adults study
Kyong Park et al.
DIABETES CARE (2009)
Concentrations of circulating P-Selectin are increased in patients with newly diagnosed insulin-dependent diabetes mellitus
H.-P. Kopp et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)
The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases
L. Vizioli et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Insulin/IGF-1 hybrid receptor expression on human platelets: consequences for the effect of insulin on platelet function
R. W. Hunter et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart
Alicia D'Souza et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension
Ranganath Muniyappa et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)
Infliximab treatment shifts the balance between stimulatory and inhibitory Fcγ receptor type II isoforms on Neutrophils in patients with rheumatoid arthritis
Kristina Belostocki et al.
ARTHRITIS AND RHEUMATISM (2008)
Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study
Naomi M. Hamburg et al.
CIRCULATION (2008)
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
Kiwon Ban et al.
CIRCULATION (2008)
Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome
Anetta Undas et al.
DIABETES CARE (2008)
Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes A Randomized Controlled Trial
Hisao Ogawa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome
Paul Holvoet et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance
Iris J. G. Ketel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Adiponectin and its association with insulin resistance and type 2 diabetes
Tianxin Sheng et al.
JOURNAL OF GENETICS AND GENOMICS (2008)
The effects of polyphenols in olive leaves on platelet function
Indu Singh et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2008)
Determinants of mean platelet volume (MPV) in an elderly population: Relevance of body fat, blood glucose and ischaemic electrocardiographic changes
Antonio Muscari et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Reactive oxygen species participate in acute renal vasoconstrictor responses induced by ETA and ETB receptors
Armin Just et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3Kα pathway
Ingeborg Hers
BLOOD (2007)
Giulio Bizzozero and the discovery of platelets
Domenico Ribatti et al.
LEUKEMIA RESEARCH (2007)
Diabetes mellitus as a prothrombotic condition
P. J. Grant
JOURNAL OF INTERNAL MEDICINE (2007)
Impact of body mass index on platelet aggregation after administration of a high loading dose of 600 mg of Clopidogrel before percutaneous coronary intervention
Dirk Sibbing et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity
Takashi Murakami et al.
THROMBOSIS RESEARCH (2007)
Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria
K. Krzyzanowska et al.
DIABETIC MEDICINE (2007)
Methods for evaluating endothelial function in humans
Ana Barac et al.
HYPERTENSION (2007)
Platelet aggregation in obese and diabetic subjects: Association with leptin level
Chiyo Sugiyama et al.
PLATELETS (2007)
Insulin resistance as a determinant of platelet activation in obese women
Stefania Basili et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Endothelial dysfunction:: a multifaceted disorder
Michel Feletou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Endothelial dysfunction and its role in diabetic vascular disease
Martin M. Hartge et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2006)
Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase
Xing Li Wang et al.
DIABETES (2006)
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Takashi Kadowaki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression
XL Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Reciprocal relationships between insulin resistance and endothelial dysfunction - Molecular and pathophysiological mechanisms
JA Kim et al.
CIRCULATION (2006)
Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes
A Natali et al.
DIABETES (2006)
Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation
XL Du et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Activation of vascular protein kinase C-β inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance
K Naruse et al.
DIABETES (2006)
Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss - An update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
P Poirier et al.
CIRCULATION (2006)
Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappa B activation
M Jove et al.
ENDOCRINOLOGY (2006)
Effects of VLDL and remnant particles on platelets
Rasaq Olufadi et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2006)
Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κB pathway in rat liver
G Boden et al.
DIABETES (2005)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus
JO Prior et al.
CIRCULATION (2005)
Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKβ
F Kim et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension
J Deanfield et al.
JOURNAL OF HYPERTENSION (2005)
Correlation between cardiovascular disease and diabetes mellitus: Current concepts
RW Nesto
AMERICAN JOURNAL OF MEDICINE (2004)
Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes
N Eibl et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
IRS-1 mediates inhibition of Ca2+ mobilization by insulin via the inhibitory G-protein Gi
IA Ferreira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Oxidative stress in the pathogenesis of diabetic neuropathy
AM Vincent et al.
ENDOCRINE REVIEWS (2004)
Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes
ZG Gao et al.
MOLECULAR ENDOCRINOLOGY (2004)
Platelet activation in type 2 diabetes mellitus
P Ferroni et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin
C Hug et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease
T Nyström et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus - Relationships to cardiovascular disease and risk factor intervention
HS Lim et al.
CIRCULATION (2004)
Dysfunction of endothelial nitric oxide synthase and atherosclerosis
S Kawashima et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
RAGE (receptor for advanced glycation end products): a central player in the inflammatory response
T Chavakis et al.
MICROBES AND INFECTION (2004)
Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles
K Itoh et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus
FK Keating et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
New markers of inflammation and endothelial cell activation - Part I
PE Szmitko et al.
CIRCULATION (2003)
Diabetes and vascular disease -: Pathophysiology, clinical consequences, and medical therapy:: Part I
MA Creager et al.
CIRCULATION (2003)
High levels of circulating endothelial microparticles in patients with acute coronary syndromes
L Bernal-Mizrachi et al.
AMERICAN HEART JOURNAL (2003)
Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products
B Xu et al.
FASEB JOURNAL (2003)
Increased platelet Fc receptor expression as a potential contributing cause of platelet hypersensitivity to collagen in diabetes mellitus
DC Calverley et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Endothelial dysfunction - A marker of atherosclerotic risk
PO Bonetti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Combating diabetes
[Anonymous]
FASEB JOURNAL (2002)
Cells in focus: endothelial cell
BE Sumpio et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)
Platelet activation in obese women -: Role of inflammation and oxidant stress
G Davì et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management
JA Beckman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
High-density lipoprotein restores endothelial function in hypercholesterolemic men
LE Spieker et al.
CIRCULATION (2002)
Inhibition of platelet-collagen interaction - An in vivo action of insulin abolished by insulin resistance in obesity
J Westerbacka et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
Insulin signalling and the regulation of glucose and lipid metabolism
AR Saltiel et al.
NATURE (2001)
Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control
JI Osende et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Endothelial perturbation in children and adolescents with type 1 diabetes -: Association with markers of the inflammatory reaction
M Romano et al.
DIABETES CARE (2001)
Platelet dysfunction in type 2 diabetes
AI Vinik et al.
DIABETES CARE (2001)
Eptifibatide and 7E3, but not tirofiban, inhibit αvβ3 integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin
M Lele et al.
CIRCULATION (2001)
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
MP Wautier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2001)
Acute hyperglycemia increases soluble P-selectin in male patients with mild diabetes mellitus
M Yngen et al.
BLOOD COAGULATION & FIBRINOLYSIS (2001)
Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro
R Assert et al.
DIABETOLOGIA (2001)
Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate
WH Kaesemeyer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells
T Inoguchi et al.
DIABETES (2000)
Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy
FH de Man et al.
ATHEROSCLEROSIS (2000)
Obesity and insulin resistance
BB Kahn et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Platelet function in patients with familial hypertriglyceridemia:: Evidence that platelet reactivity is modulated by apolipoprotein E content of very-low-density lipoprotein particles
J Pedreño et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes
Z Mallat et al.
CIRCULATION (2000)
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
E Bonora et al.
DIABETES CARE (2000)
Endothelin 1 transcription is controlled by nuclear factor-kappa B in AGE-stimulated cultured endothelial cells
P Quehenberger et al.
DIABETES (2000)
Share Paper
